Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
100 Cards in this Set
- Front
- Back
Hydrochlorothiazide Brand
|
Microzide
|
|
Hydrochlorothiazide Therapeutic Class
|
Diuretic
Thiazide |
|
Hydrochlorothiazide Common Indications
|
Hypertension
|
|
Hydrochlorothiazide Common Dosing
|
Oral 12.5-50 mg/day
|
|
Hydrochlorothiazide Absolute CIs
|
Hypersensitivity to...
-HCTZ -Thiazides -Sulfonamide-derived drugs Renal Decompensation Pregnancy |
|
Hydrochlorothiazide Common Side Effects
|
HoTN
Phototoxicity Vertigo |
|
Hydrochlorothiazide Serious Side Effects
|
HYPER calcemia, glycemia, phosphatemia
HYPO kalemia, magnesemia, natremia Cardiac dysrhythmia Pancreatitis Cholestatic Jaundice Syndrome Glaucoma Renal Failure Renal impairment |
|
Hydrochlorothiazide Pregnancy
|
B
|
|
Hydrochlorothiazide Admin
|
May admin c food or milk; take early in day to avoid nocturia (no later than 6 pm unless instructed otherwise)
|
|
Hydrochlorothiazide MOA
|
Hydrochlorothiazide is an antihypertensive and diuretic agent that affects the electrolyte reabsorption at the distal renal tubule resulting in increased excretion of sodium and chloride in equal amounts.
|
|
Acetazolamide Brand
|
Diamox
|
|
Acetazolamide Therapeutic Class
|
Anticonvulsant
Carbonic Anhydrase Inhibitor; Diuretic Opthalmic Agent, Antiglaucoma |
|
Acetazolamide Common Indications
|
Mountain or altitude sickness
Urine alkalinization |
|
Acetazolamide Common Dosing
|
Mountain sickness: oral 500-1000 mg daily Q 8-12 hr (IR) or Q 12-24 hr (ER)
Urine alkalinization: oral 5 mg/kg/dose bid or tid |
|
Acetazolamide Absolute CIs
|
Hypersensitivity to acetazolamide or sulfonamides
Hepatic disease or insufficiency DEC Na or K levels Adrenocortical insufficiency Cirrhosis Hyperchloremic acidosis Severe renal disease Severe pulmonary obstruction |
|
Acetazolamide Common Side Effs
|
?
|
|
Acetazolamide Serious SEs
|
SJS
TEN due to drug acidosis metabolic acidosis agranulocytosis aplastic anemia thrombocytopenia hepatic necrosis anaphylaxis angle closure glaucoma |
|
Acetazolamide Pregnancy
|
C
|
|
Acetazolamide Administration
|
may admin with food
cause alteration in taste use cherry or chocolate syrup to disguise taste of druge but not fruit juices |
|
Acetazolamide MOA
|
inhibits carbonic anhydrase from catalyzing the reversible hydration of carbon dioxide and dehydration of carbonic acid. In the eye, carbonic anhydrase inhibition reduces aqueous humor production resulting to a decrease in intraocular pressure. It also delays abnormal, paroxysmal excessive discharge from central nervous system neurons and affects promotion of diuresis and urinary alkalinization
|
|
Furosemide Brand
|
Lasix
|
|
Furosemide Therapeutic class
|
diuretic, loop
|
|
Furosemide CI
|
edema in heart failure
|
|
Furosemide Comm Dosing
|
Oral: 20-80 mg/dose
IM/IV: initial 20-40 mg/dose Cont IV: -bolus: 20-40 mg/dose over 1-2 min -cont 10-40 mg/hr |
|
Furosemide Absolute CI
|
Hypersensitivity
anuria fluid and electrolyte depletion |
|
Furosemide Comm SE
|
HYPERURICEMIA (40%)
Hypomagnesemia loss of app spasm of bladder |
|
Furosemide Serious SE
|
Orthostatic hypotension
Erytheme multiforme SJS Pancreatitis Agranulocytosis and aplastic anemia are rare thrombocytopenia |
|
Furosemide Pregnancy
|
C
|
|
Furosemide Admin
|
IV inj should be given slowly
admin on empty stomack c food or milk if GI distress (can reduce diuretic efficacy |
|
Furosemide MOA
|
Furosemide is an anthranilic acid derivative and a potent diuretic that works by blocking the absorption of sodium and chloride in the kidney tubules (proximal and distal tubules, also in the loop of Henle), causing a profound increase in urine output
|
|
Spironolactone Brand
|
Aldactone
|
|
Spironolactone Therapeutic Class
|
Diuretic, Potassium Sparing
Selective aldosterone blocker |
|
Spironolactone Comm Indication
|
edema or heart failure
|
|
Spironolactone Comm Dosing
|
Oral 25-200 mg/day in 1-2 divided doses
Severe HF: 12.5-25 mg/day... max 50 mg/day |
|
Spironolactone Absolute CI
|
Anuria
Acute renal insufficiency Sig impairment of renal excretory fxn Hyperkalemia bbw tumorigenic |
|
Spironolactone Common SEs
|
Rash, urticaria, gynecomastia, NVD, stomach cramps, HA, lethargy, somnolence, confusion, menstruation disorder, impotence
|
|
Spironolactone Serious SEs
|
Skin uler
Hyperkalemia Metabolic acidosis gastric hemorrhage gastritis agranulocytosis sle breast cancer |
|
Spironolactone Pregnancy
|
C
|
|
Spironolactone Admin
|
taken with food
-dec gi irritation excessive K intake should be avoided |
|
Spironolactone MOA
|
It inhibits the effect of aldosterone by competing for the aldosterone-dependent sodium-potassium exchange site in the distal tubule cells. This increases the secretion of water and sodium, while decreasing the excretion of potassium
|
|
Sodium Polystyrene Sulfonate Brand
|
Kayexalate
|
|
Sodium Polystyrene Sulfonate Therapeutic Class
|
Antidote
|
|
Sodium Polystyrene Sulfonate Comm Indic
|
hyperkalemia
|
|
Sodium Polystyrene Sulfonate Comm Dosing
|
oral 15g 1-4 times/day
rectal 30-50 g every 6 hrs |
|
Sodium Polystyrene Sulfonate Abs CI
|
Hypersensitivity
-hypokalemia -obstructive bowel disease -neonates with reduced gut motility -oral admin in neonates! |
|
Sodium Polystyrene Sulfonate Common SEs
|
Constipation
nv |
|
Sodium Polystyrene Sulfonate Serious SEs
|
Hypocalcemia
Hypokalemia Fecal Impaction GI Hemorrhage GI necrosis GI obstruction/perforation ischemic colitis acute bronchitis bronchopneumonia |
|
Sodium Polystyrene Sulfonate Pregnancy
|
C
|
|
Sodium Polystyrene Sulfonate Admin
|
Shake suspension well
do not mix with orange juice oral admin more eff |
|
Sodium Polystyrene Sulfonate MOA
|
Local: Antihyperkalemic—In the intestine (mostly the large intestine), sodium ions are released and are replaced by potassium and other cations before the resin is passed from the body.
|
|
Calcitriol Brand
|
Rocaltrol
|
|
Calcitriol Therapeutic Class
|
Vit D analog
|
|
Calcitriol Comm Indics
|
Vit D therapy in CKD
|
|
Calcitriol Common Dosing
|
oral .25 mcg/day
|
|
Calcitriol Absolute CIs
|
hypersensitivity
hypercalcemia vit d toxicity |
|
Calcitriol Common SEs
|
hypercalcemia
|
|
Calcitriol Serious SEs
|
acute blistering dermatitis
poisoning by vit d hypercalcemia syndrome |
|
Calcitriol Pregnancy
|
C
|
|
Calcitriol Admin
|
admin with regard to food
|
|
Calcitriol MOA
|
an active form of vitamin D(3) or cholecalciferol, stimulates calcium transport in the intestines, its resorption in bones and tubular reabsorption in the kidney. It also suppresses the parathyroid hormone (PTH) secretion and synthesis
|
|
Ergocalciferol Brand
|
Drisdol
|
|
Ergocalciferol Therapeutic Class
|
Vit D Analog
|
|
Ergocalciferol Comm Indics
|
Vit D deficiency/insuff in CKD
|
|
Ergocalciferol Common Dosing
|
look at dosing
|
|
Ergocalciferol Absolute CIs
|
Hypersensitivity
hypercalcemia malabsorption syndrome hypervitaminosis d or abnormal sensitivity to toxic effs of vit d |
|
Ergocalciferol Common SEs
|
n/a
|
|
Ergocalciferol Serious SEs
|
hypercalcemia
hypervitaminosis d renal impairment calcification of soft tissues bone demineralization growth retardation nc mild acidosis wt loss |
|
Ergocalciferol pregnancy
|
c
|
|
Ergocalciferol admin
|
n/a
|
|
Ergocalciferol moa
|
Ergocalciferol, or vitamin D(2), promotes active absorption of calcium and phosphorus, thus increasing serum calcium and phosphate levels sufficiently to allow bone mineralization. It also mobilizes calcium and phosphate from bone and increases the reabsorption of calcium and phosphate by the renal tubules
|
|
Desmopressin Brand
|
DDAVP
|
|
Desmopressin Therapeutic Class
|
Antihemophillic agent
hemostatic agent vasopressin analog, synthetic |
|
Desmopressin Comm Indics
|
Diabetes insipidus
|
|
Desmopressin Comm dosing
|
look at dosing
|
|
Desmopressin Abs CIs
|
hypersensitivity hyponatremia
history of mod to sev renal impairment |
|
Desmopressin Comm SEs
|
flushing
nausea fatigue ha |
|
Desmopressin Serious SEs
|
abnormal bp (infreq)
inc hr hyponatremia hyposmolality water intox syndrome thromboembolic disorder acute allergic rxn anaphylaxis and seizure rare |
|
Desmopressin Pregnancy
|
B
|
|
Desmopressin Admin
|
withdraw dose from ampule... further dilution not reqd
admin as direct inj |
|
Desmopressin moa
|
Desmopressin acetate is a synthetic analogue of the naturally occurring hormone 8-arginine vasopressin (ADH) and an antidiuretic hormone that affects conservation of water in the kidneys. It has lesser vasopressor activity and action on visceral smooth muscles relative to the enhanced antidiuretic activity.
|
|
Pot Chl Brand
|
Klor-Con
|
|
Pot Chl Therapeutic Class
|
Electrolyte supplement
oral/parenteral |
|
Pot Chl Comm Indics
|
prevention hypokalemia
tx hypokalemia |
|
Pot Chl Comm Dosing
|
Prevention: oral/iv 20-40 meQ/DAY
TX: 40-100 meq/day divided in 2-5 doses |
|
Pot Chl Abs CI
|
hypersensitivity hyperkalemia
oral ci in pt with gi tract passage delays |
|
Pot Chl Comm SEs
|
NVD
flatulence |
|
Pot Chl Serious SEs
|
Cardiac arrest
abnormal ecg hyperkalemia abdominal pain gi ulcer |
|
Pot Chl pregnancy
|
c
|
|
Pot Chl admin
|
with meals and full glass of water to minimize gi irritation
|
|
Pot Chl moa
|
Potassium chloride, an electrolyte replenisher, participates in several physiological processes in the body including the transmission of nerve impulses, the maintenance of normal renal function and intracellular tonicity, and the contraction of skeletal, cardiac and smooth muscle
|
|
Bosentan Brand
|
Tracleer
|
|
Bosentan Therapeutic Class
|
Endothelin antagonist
Vasodilator |
|
Bosentan Comm Indics
|
Pulmonary artery HTN
|
|
Bosentan Comm Dosing
|
oral <40 kg
initial and maint 62.5 mg oral >40kg initial 62.5 mg maint 125 mg bid |
|
Bosentan Absolute CI
|
HYPERSENSITIVITY CONCURRENT USE OF CYCLOSPORINE OR GLYBURIDE
pregnancy |
|
Bosentan Comm SEs
|
Edema of lower extremity
hypotension palpitations flushing dec hgb ha |
|
Bosentan Serious SEs
|
dec hgb
liver cirrhosis inc liver aminotransferase level liver failure angioedema |
|
Bosentan Pregnancy
|
C
|
|
Bosentan Admin
|
may admin with or without food
once am once pm |
|
Bosentan moa
|
Bosentan is a dual endothelin receptor antagonist.
Bosentan decreases both pulmonary and systemic vascular resistance resulting in increased cardiac output without increasing heart rate. |